Oral bisphosphonates and osteonecrosis of the jaw.
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland, Baltimore, USA.
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000517:prevention & control*; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates